image_alt_text
9

Douglas Lauffenburger, Ph.D.

AIMBE College of Fellows Class of 1992
For a pioneering role in developing cellular bioengineering through research and training in the area of receptor-mediated cell behavior.

Douglas Lauffenburger honored for contributions to biological engineering education

Via MIT | March 11, 2021

Professors awarded the National Academy of Engineering’s prestigious Bernard M. Gordon Prize for Innovation in Engineering and Technology Education.

The National Academy of Engineering (NAE) has announced that two MIT professors have been jointly awarded the Bernard M. Gordon Prize for Innovation in Engineering and Technology Education, the most prestigious engineering education award in the United States.

Linda G. Griffith, the School of Engineering Professor of Teaching Innovation in the Department of Biological Engineering, and Douglas A. Lauffenburger, the Ford Professor of Biological Engineering, Chemical Engineering and Biology, were recognized for their respective contributions to “the establishment of a new biology-based engineering education, producing a new generation of leaders capable of addressing world problems with innovative biological technologies,” according to an NAE statement… Continue reading.

 

A Breakthrough in Endometriosis Research

Via MIT Libraries News | February 26, 2014

Over the years Linda Griffith has undergone many surgeries for endometriosis, a condition in which tissue that normally grows in the uterus is found elsewhere in the body and can cause lesions, inflammation, and infertility. The disease is poorly understood, and so it made sense to Griffith, a professor of biological and mechanical engineering, to start researching it. In a paper published earlier this month, Griffith and colleagues, including bioengineering professor Douglas Lauffenburger, studied pelvic fluid from women with endometriosis and in about a third they found elevated levels of a group of immune system proteins. The work is an early step towards classifying the disease and, eventually, finding new treatments for it. “We’re not claiming we found a mechanism — the mechanism for endometriosis,” Griffith told the Boston Globe. “We have found a very convincing approach to understand an immune network.”